We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




An Organism's Genetic Background Influences how Mutant Genes Are Expressed

By LabMedica International staff writers
Posted on 19 Aug 2013
Print article
Image: By focusing on fruit fly wings and a genetic mutation that alters them, Michigan State University researchers demonstrated the influence of wild type genetic background was actually quite common  (Photo courtesy of Michigan State University).
Image: By focusing on fruit fly wings and a genetic mutation that alters them, Michigan State University researchers demonstrated the influence of wild type genetic background was actually quite common (Photo courtesy of Michigan State University).
Expression of a phenotype caused by a mutation in a gene or set of genes is heavily influenced by interactions among the other genes that make up the genome of the organism.

Investigators at Michigan State University (East Lansing, USA) worked with the fruit fly Drosophila melanogaster, an intensively studied model system for human genetic interactions.

They focused on a genetic mutation that alters the shape of fruit fly wings and discovered that about 75% of the time the individual fly's wild type genetic background affected the expression of the mutated gene. This finding was published in the August 1, 2013, online edition of the journal PLOS Genetics.

"It has been known for a while that genetic mutations can modify each other's effects," said senior author Dr. Ian Dworkin, associate professor of zoology at Michigan State University. "And we also know that the subtle differences in an individual's genome—what scientists call wild type genetic background—also affects how mutations are manifested."

Many disorders with a suspected genetic component, such as cancer, asthma, or Parkinson's disease, have been linked to interactions between more than one set of genes. "Is it just the two pairs of genes that are interacting?" asked Dr. Dworkin. "Or is it that the two genes are interacting and then many other genes are modifying that reaction? This will help us understand how much complexity is involved."

Related Links:

Michigan State University



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Liquid biopsy could detect and monitor aggressive small cell lung cancer (Photo courtesy of Shutterstock)

Blood-Based Test Detects and Monitors Aggressive Small Cell Lung Cancer

Small cell lung cancer (SCLC) is a highly aggressive type of cancer known for its ability to metastasize. The behavior of tumors is largely governed by which genes are turned on, or transcribed, irrespective... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.